U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Animal & Veterinary
  3. Science & Research
  4. Gregory Tyson
  1. Science & Research

Gregory Tyson PhD.

Gregory Tyson PhD.
Gregory Tyson PhD.

Division of One Health Monitoring

Biography

Dr. Gregory Tyson is the Director of the Division of One Health Monitoring (DOHM), which contains the National Antimicrobial Resistance Monitoring System (NARMS) and the Veterinary Laboratory Investigation and Response Network (Vet-LIRN). He received his PhD in microbiology from Northwestern University and joined the FDA in 2014. For several years he performed research to support NARMS and later joined Vet-Lirn as its director.  In 2022 he become the division director for the newly created DOHM. NARMS uses a one health approach to conduct surveillance of antimicrobial resistance of foodborne pathogens in retail meats and seafood, Humans and food animals within its network of 25 public health labs and universities, the Centers for Disease prevention (CDC and the U.S. Department of Agriculture (USDA) . Vet-LIRN comprises a network of 46 veterinary diagnostic laboratories that support various efforts within CVM, including performing non-regulatory testing of food or animal samples in response to consumer complaints about CVM-regulated products.

Research

NARMS’s work focuses on Antimicrobial Resistance and includes the following:

  • Monitor trends in antimicrobial resistance from various sources
  • Conduct research to better understand the emergence, persistence and spread of antimicrobial resistance
  • Disseminate timely information on antimicrobial resistance in microorganisms to stakeholders to help promote interventions and reduce resistance among foodborne bacteria.

Vet-LIRN’s work focuses in several areas, including

  • Responding to consumer complaints received by CVM’s Office of Surveillance and Compliance, including non-regulatory testing conducted by Vet-LIRN laboratories
  • Development and evaluation of methods by Vet-LIRN laboratories to detect potential issues in CVM-regulated products, with a focus on animal foods
  • Conducting antimicrobial resistance monitoring of foodborne and zoonotic pathogens in animals, using this information as part of One Health AMR monitoring
  • Supporting the COVID-19 pandemic response, including the development and expansion of methods for testing in animals

Select Publications

Mitchell PK, Wang L, Stanhope B, Tyson GH, Timme R, Strain E, Reimschuessel R, Ceric O, Goodman LB. Multi-laboratory evaluation of the Illumina iSeq platform for whole genome sequencing of Salmonella, Escherichia coli, and Listeria. Microb Genom. 2022 Feb;8(2):000717.

Feldgarden M, Brover, Gonzalez-Escalona N, Frye J, Haendiges J, Haft DH, Hoffmann M, Pettengill JB, Prasad AB, Tillman GE, Tyson GH, Klimke W. AMRFinderPlus and the Reference Gene Catalog Enable Exploration of the Genomic Links Among Antimicrobial Resistance, Stress Response, and Virulence. Sci Rep. 2021 Jun 16;11(1):12728.

Tyson GH, Ceric O, Guag J, Nemser S, Borenstein S, et al. Genomics Accurately Predicts Antimicrobial Resistance in Staphylococcus pseudintermedius Collected as Part of Vet-LIRN Resistance Monitoring. Vet Microbiol. 2021 Mar;254:109006.

Cole SD, Peak L, Tyson GH, Reimschuessel R, Ceric O, Rankin SC. New Delhi Metallo-β-Lactamase-5–Producing Escherichia coli in Companion Animals, United States. Emerg Infect Dis. 2020 Feb;26(2):381-383.


Contact Information
Gregory Tyson
+1 (240) 402-5426
+1 (301) 210-4685
Back to Top